Stocks to buy: Granules India, MGL, HDFC Life and HUL — share market expert recommendations

Posted by

New Delhi: Stock market expert Avani Bhatt suggested 4 stocks — Granules India, Mahanagar Gas (MGL), HDFC Life, and Hindustan Unilever (HUL) — which investors can enter for near-to-long-term gains. The Nifty is likely to hit 22,400-22,500 if the Nifty crosses 22,200 levels, she said in a chat with News9live. The Sensex was down 361.64 points to 72,470.30 on Tuesday, while the Nifty was at 22,004.70, down 92.05 points.

Granules India

Granules India share price was at Rs 433.50 apiece on Tuesday. Avani Bhatt, AVP at JM Financial said investors can enter the stock at Rs 430 apiece. She shared a target price of Rs 455 apiece, and a stop loss at Rs 415 per share. Drug manufacturer Granules India reported a Q3 net profit of Rs 1,260 crore, up 1.6 per cent on-year basis.

Mahanagar Gas (MGL)

Bhatt said investors can purchase the stock at Rs 1320-1340 per share. The stock was trading at Rs 1,356 apiece as of Tuesday. Bhatt shared a target price of Rs 1,435 apiece over a 15-20 day range. She suggested a stop loss at Rs 1,285 apiece for MGL share price. Mahanagar Gas reported an 84 per cent jump in Q3 net profit to Rs 317.18 crore.

HDFC Life

HDFC Life share price was at Rs 627.70 apiece on Tuesday, Avani Bhat suggested that investors can enter the stock at Rs 620-623 apiece with a target price of Rs 645/652 per share. Bhatt suggested stop loss at Rs 608 apiece for HDFC Life share price. HDFC Life’s Q3 results showed a 6 per cent jump in net premium income to Rs 15,273 crore.

Hindustan Unilever

FMCG major HUL’s share price has undergone correction and is expected to go up gradually, said Bhatt. She suggested entering the stock at Rs 2,244 apiece, with a target price of Rs 2,320/2,375 per share. HUL share price stop loss has been suggested at Rs 2,210 per share. HUL reported a 0.38 per cent slip in third quarter net profit ot Rs 14,928 crore.

(Disclaimer: This article is only meant to provide information. News9live.com does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)

Click to rate this post!
[Total: 0 Average: 0]

Leave a Reply

Your email address will not be published. Required fields are marked *